人血小板裂解物市场：按类型、按应用、按最终用户、按地区 - 规模、份额、展望、机会分析，2023-2030 年

一种名为人血小板裂解物的富含生长因子的细胞培养补充剂是在美国食品和药物管理局 (FDA) 和加拿大卫生部许可的血液设施中由健康供体人血小板製成的。它是 多个供体单位在製造过程中汇集在一起，以减少批次间的差异。 为防止凝血，应添加抗凝血剂。 由人血小板製成的细胞培养生长补充剂称为人血小板裂解物 (HPL)。 用 HPL 代替胎牛血清 (FBS) 消除了异种问题和牛朊病毒的传播，从而提高了干细胞产量和临床级潜力。 用于细胞培养的人血小板裂解物补充剂可提供卓越的细胞性能和可重现的结果。 它也是标准化和安全的。 许多实验和临床研究项目都受益于人类血小板裂解物的开发。 人血小板裂解物不影响功能能力。 可以使用血浆、血清、脐带血血清和血小板裂解物等人血来源物质代替胎牛血清。 人血小板裂解物用于多种应用，包括生物技术和製药领域突破性疗法的研发和製造。

市场动态

越来越多地采用无机策略，例如市场主要参与者的收购，预计这将在预测期内推动市场增长。 例如，2021 年 8 月，生物技术公司 BioLife Solutions 宣布收购生物技术公司 sexton biotechnologies，以扩大其细胞和基因治疗工具的产品组合。 Sexton 的生物生产工具组合包括用于细胞治疗最终剂量包装的专有封闭小瓶、人血小板裂解物 (HPL) 培养基、用于细胞製造的胎牛血清或人血清的生物定义替代品、自动细胞处理机等。

这项研究的主要特点

• 本报告对全球人类血小板裂解物市场进行了深入分析，提供了以 2022 年为基准年的预测期 (2023-2030) 的市场规模和復合年增长率 (CAGR%)。我是这里。
• 它揭示了各个细分市场的潜在收入机会，并描述了该市场具有吸引力的投资建议矩阵。
• 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 全球人血小板裂解物市场主要参与者的概况基于以下参数，包括公司亮点、产品组合、主要亮点、财务业绩和战略。
• 本研究涵盖的主要公司包括 STEMCELL Technologies Inc.、Merck KGaA、Mill Creek Life Sciences、Merck & Co., Inc、AventaCell BioMedical、Compass Biomedical, Inc、Macopharma SA、Trinova Biochem GmbH、PL BioScience GmbH , Cook Regentec, Life Science Group Ltd., BBI Solutions, Regenexx, Thermo Fisher Scientific。
• 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 《全球人血小板裂解物市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球人类血小板裂解物市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写

第二章市场展望

• 报告概述
  • 市场定义和范围
• 执行摘要
  • 市场概况：按类型分类
  • 市场概况：按应用分类
  • 市场概况：按最终用户分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场机会
• 影响分析
• 市场趋势
• 近期发展趋势
• 收购和合作场景
• 技术概述
• 监管情景
• 害虫分析

第 4 章全球人血小板裂解物市场 - 冠状病毒 (COVID-19) 大流行的影响

• 总体影响
• 对供需的影响
• COVID-19 对市场的影响

第 5 章全球人类血小板裂解物市场，按类型，2017-2030

• 基于肝素的人血小板裂解物
• 不含肝素的人血小板裂解物

第 6 章全球人类血小板裂解物市场应用，2017-2030

• 临床应用
• 用于研究

第 7 章全球人类血小板裂解物市场：按最终用户分类，2017-2030

• 生物製药公司
• 签约研发组织
• 其他

第 8 章全球人类血小板裂解物市场：地区，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第9章竞争格局

• STEMCELL Technologies Inc
• Merck KGaA
• Mill Creek Life Sciences
• Merck & Co., Inc
• AventaCell BioMedical
• Compass Biomedical, Inc
• Macopharma SA
• Trinova Biochem GmbH
• PL BioScience GmbH
• Cook Regentec
• Life Science Group Ltd
• BBI Solutions
• Regenexx
• Thermo Fisher Scientific

第 10 章

• 调查方法
• 关于出版商

A growth factor-rich cell culture supplement called human platelet lysate is made from healthy donor human platelets at blood facilities that are approved by both the U.S. Food and Drug Administration (FDA) and Health Canada. To reduce lot-to-lot variability, several donor units are pooled together during the production process. To prevent coagulation, an anticoagulant must be added. A supplement for cell culture growth made from human platelets is called human platelet lysate (HPL). By removing xenogeneic concerns and the spread of bovine prions, replacing foetal bovine serum (FBS) with HPL enables the increase and possible clinical grade production of stem cells. The human platelet lysate supplements for cell culture offer great cell performance and repeatable results. They are standardized and safe. Numerous experimental and clinical research projects have benefited from the development of human platelet lysates. Functional capacities are unaffected by human platelet lysates. Human blood-derived substances such as plasma, serum, umbilical cord blood serum, and platelet derivatives such platelet lysates can be used instead of FBS. Human platelet lysates have several uses, including biotechnology and pharmaceutical medication breakthrough therapy research, development, and production.

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as acquisitions is expected to drive market growth over the forecast period. For instance, in August 2021, BioLife Solutions, a biotechnology company, announced the acquisition of sexton biotechnologies, a biotechnology company, to expand cell and gene therapy tools portfolio. Sexton's bio production tools portfolio includes proprietary closed vials for cell therapy final dose packaging, human platelet lysate (HPL) media, a bio-defined replacement for fetal bovine serum or human serum used in cell manufacturing, and automated cell processing machines.

Key features of the study:

• This report provides in-depth analysis of the global human platelet lysate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global human platelet lysate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include STEMCELL Technologies Inc., Merck KGaA, Mill Creek Life Sciences, Merck & Co., Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH, Cook Regentec, Life Science Group Ltd., BBI Solutions, Regenexx, Thermo Fisher Scientific.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global human platelet lysate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human platelet lysate market

Detailed Segmentation:

• Global Human Platelet Lysate Market, By Type:
  • Heparin - Based Human Platelet Lysate
  • Heparin - Free Human Platelet Lysate
• Global Human Platelet Lysate Market, By Application:
  • Clinical Use
  • Research Use
• Global Human Platelet Lysate Market, By End User:
  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Others
• Global Human Platelet Lysate Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • STEMCELL Technologies Inc
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
  • Mill Creek Life Sciences
  • Merck & Co., Inc
  • AventaCell BioMedical
  • Compass Biomedical, Inc
  • Macopharma SA
  • Trinova Biochem GmbH
  • PL BioScience GmbH
  • Cook Regentec
  • Life Science Group Ltd.
  • BBI Solutions
  • Regenexx
  • Thermo Fisher Scientific

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Human Platelet Lysate Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Human Platelet Lysate Market, By Type , 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Heparin - Based Human Platelet Lysate
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Heparin - Free Human Platelet Lysate
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Human Platelet Lysate Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Clinical Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Research Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Human Platelet Lysate Market, By End User, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Biopharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Contract Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Human Platelet Lysate Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• STEMCELL Technologies Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mill Creek Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck & Co., Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• AventaCell BioMedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Compass Biomedical, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Macopharma SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Trinova Biochem GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• PL BioScience GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cook Regentec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Life Science Group Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BBI Solutions
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Regenexx
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us